Now showing items 431-438 of 438
Clinical Activity Of Loncastuximab Tesirine Plus Ibrutinib In Non‐Hodgkin Lymphoma: Updated Lotis 3 Phase 1 Results
(Wiley Periodicals, Inc., 2021-06)
Knockdown of Notch1 inhibits nasopharyngeal carcinoma cell growth and metastasis via downregulation of CCL2, CXCL16, and uPA
(Wiley Periodicals, Inc., 2019-10)
Notch pathway is a highly conserved cell signaling system that plays very important roles in controlling multiple cell differentiation processes during embryonic and adult life. Multiple lines of evidence support the ...
Impact of initial chemotherapy regimen on outcomes for patients with double- expressor lymphoma: A multi- center analysis
(Wiley Periodicals, Inc., 2021-10)
Diffuse large B- cell lymphoma featuring overexpression of MYC and B- Cell Lymphoma 2 (double expressor lymphoma, DEL) is associated with poor outcomes. Existing evidence suggesting improved outcomes for DEL with the use ...